Daxor Corporation Common Stock
Symbol: DXR (NASDAQ)
10.95
▼ (-3.68%) -0.418
Company Description:
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Key Stats
- Today's Open: $11.08
- Today's High: $11.685
- Today's Low: $10.95
- Today's Volume: 8.71K
- Yesterday Close: $11.3681
- Yesterday High: $11.6
- Yesterday Low: $11.3681
- Yesterday Volume: 937
- Last Min Volume: 50
- Last Min High: $10.95
- Last Min Low: $10.95
- Last Min VWAP: $10.95
Company Profile
- Name: Daxor Corporation Common Stock
- Website: https://www.daxor.com
- Listed Date: 1983-07-25
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0000027367
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $56.66M
- Round Lot: 100
- Outstanding Shares: 4.98M
- Asset Type: CS
RECENT FILINGS FOR DXR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-02 | N-PX | View |
| 2025-09-02 | NT NPORT-P | View |
| 2025-08-29 | N-CSR | View |
| 2025-08-07 | 8-K | View |
| 2025-07-24 | N-2/A | View |
| 2025-07-24 | N-CEN/A | View |
| 2025-07-24 | N-CEN/A | View |
| 2025-07-01 | 8-K | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-13 | 40-17F2 | View |
| 2025-06-12 | 40-17F2 | View |
| 2025-06-11 | 40-17F2 | View |
| 2025-06-06 | DEF 14A | View |
| 2025-05-27 | NPORT-P | View |
| 2025-04-07 | 4 | View |
| 2025-03-27 | 4 | View |
| 2025-03-20 | 4/A | View |
Latest News on DXR